TSHR and Graves disease: These compounds, including antagonists and inverse agonists, are of minimal/mild effectiveness in suppressing TSHR signal transduction, as only around 50% and 39% inhibitory effects for cAMP production could be achieved when stimulated by TSH or sera derived from patients with Graves’ disease, respectively [129,130].